10.4 Endovenous Ablation Surveillance & EHIT Classification
Key Takeaways
Routine early DVT/ARTE screening duplex is not recommended for every average-risk asymptomatic patient after thermal ablation.
Symptomatic and high-risk patients require the appropriate early assessment; nonthermal follow-up recommendations differ.
ARTE is the broader term; EHIT specifically concerns thermal treatment.
Class II occupies <50% of the deep lumen, Class III >50% without complete occlusion, and Class IV is occlusive DVT.
Document closure, the proximal margin, deep extension, symptoms, and communication; medication decisions are individualized.
Know the treatment and why follow-up was requested
Endovenous ablation closes an incompetent superficial vein using thermal or nonthermal methods. Thermal methods include radiofrequency and laser; nonthermal methods include adhesive and mechanochemical approaches. The procedure, treated vein, junction anatomy, symptoms, thrombotic risk, and clinical plan determine the follow-up question. Avoid assuming every patient had the same device or requires the same immediate scan.
Thermal treatment commonly uses ultrasound-guided tumescent anesthesia to provide analgesia, compress the vein, and separate/protect surrounding structures from heat. Formulation, dose, catheter position, energy, and treatment length are procedure-specific decisions. A study guide should not present an unsourced universal anesthetic recipe or imply that tumescence guarantees painless treatment and zero injury. Nonthermal methods have different risks and do not eliminate the need for clinical assessment.
Current early-ultrasound recommendations
The 2023 SVS/AVF/AVLS guideline recommends against routine early duplex to detect ablation-related thrombus extension or DVT in average-risk, asymptomatic patients after thermal ablation. It recommends early duplex for symptomatic patients after thermal or nonthermal ablation and supports early examination of high-risk asymptomatic patients. After nonthermal treatment, early duplex may be performed in an average-risk asymptomatic patient. State the risk group and modality rather than declaring an examination mandatory for everyone at 48–72 hours.
A referring service may request follow-up for closure, persistent symptoms, recurrent varicosities, or another specific concern. Follow the order and protocol while recognizing the distinction between a closure assessment and screening every low-risk patient for thrombosis. New chest pain, dyspnea, marked swelling, or neurologic deterioration requires urgent clinical assessment rather than waiting for a scheduled appointment.
Perform the requested postoperative assessment completely
Review the treatment report and identify the treated segment and its junction with the deep system. Assess the accessible treated vein, proximal closure margin, adjacent deep vein, and any additional symptomatic or protocol-required segments. Use grayscale compression where appropriate, color, and spectral Doppler. Record the distance of the proximal closure/thrombus margin from the junction and any extension into the deep vein.
A successfully closed segment generally lacks luminal flow and is noncompressible. Its diameter and echogenicity evolve with time; it need not already be a uniformly shrunken bright cord at 48 hours. Color silence alone is insufficient if settings are inappropriate. Partial residual flow or later recanalization should be described by extent and reflux rather than labeled a complete success.
The intended treatment endpoint depends on device instructions and anatomy. Do not apply one universal 1–2 cm safe distance to every procedure. Document what was observed and compare with the treatment plan. Evaluate the deep system when the indication, symptoms, risk, or protocol calls for it.
EHIT and the broader ARTE terminology
Endovenous heat-induced thrombosis (EHIT) describes extension related to thermal treatment. Ablation-related thrombus extension (ARTE) is the broader term used for extension after thermal or nonthermal procedures. The commonly used four-class framework describes its relationship to the deep vein:
| Class | Extent |
|---|---|
| I | Reaches the junction without meaningful extension into the deep lumen |
| II | Extends into the adjacent deep vein and occupies <50% of its lumen |
| III | Extends into the deep vein and occupies >50%, without complete occlusion |
| IV | Occlusive deep venous thrombosis |
Class I can be subdivided in some systems. State the classification used and describe the actual anatomy; a borderline measurement or unusual extension should not be forced into a category without explanation. Measure deep-lumen involvement in an appropriate plane and distinguish the treated superficial segment from an untreated deep vein.
Classification informs clinical management
Class II often prompts surveillance and individualized risk assessment rather than the same anticoagulant regimen for everyone. The 2020 AVF/SVS EHIT guideline describes weekly surveillance for Class II, with consideration of medication in higher-risk patients, and therapeutic anticoagulation with surveillance for Class III until retraction/resolution to the junction. Current ARTE guidance also considers symptoms, procedure, risk, and thrombus extent. Class IV is managed as DVT under the clinical team's treatment framework.
Do not prescribe an arbitrary “one or two weeks for everyone” or “three to six months for every extension.” Anticoagulant choice and duration depend on classification and clinical circumstances. The sonographer's role is accurate measurement, documentation, and timely communication. A treatment-related finding still deserves documentation even if the expected response is observation.
Worked cases
A treated GSV is closed and a thrombus tip protrudes into the common femoral vein, occupying about 30% of the lumen. This is Class II under the stated four-class scheme. Record the tip, deep-vein involvement, and remaining flow and communicate to the responsible clinician. Surveillance and medication decisions follow risk and the treating plan; calling it Class IV because any deep extension exists would be wrong.
A second patient has no symptoms and is average-risk after uncomplicated thermal ablation. Current society guidance does not require routine early DVT/ARTE screening duplex in every such patient. A third patient develops new calf swelling and pain after treatment; early duplex is indicated for evaluation. The symptom and risk context changes the answer even though the procedure name is identical.
Other findings and follow-up
Assess collections, local tenderness, superficial phlebitis, and other visible abnormalities when relevant. Nerve symptoms, skin injury, infection, or allergic reactions require clinical assessment and cannot be excluded by a closed-vein image. Recurrent varicosities may reflect recanalization, an untreated accessory pathway, perforator disease, or another source. Map the actual pathway rather than assuming the original trunk is always responsible.
2023 varicose-vein/ARTE guideline and AVF/SVS EHIT guideline — checked October 18, 2026.
An average-risk patient is asymptomatic after uncomplicated thermal saphenous ablation. What does the 2023 guideline recommend about routine early screening for ARTE/DVT?
It is mandatory at 48 hours in every patient
It is mandatory twice daily
It is not routinely recommended in this group; symptoms or high-risk status change the assessment
A closed superficial vein excludes future DVT
Thrombus extends from a treated GSV into 30% of the common femoral lumen. Which classification and response are appropriate?
Class I; erase the finding
Class IV; every case needs the same six-month regimen
Class II; document and communicate for surveillance and individualized risk-based management
Normal anatomy requiring no documentation
A patient returns for follow-up duplex ultrasound 48 hours after endovenous laser ablation of the proximal great saphenous vein. Which sonographic finding confirms technical success of the ablation procedure?
A widely patent, thin-walled vein lumen displaying spontaneous and respiratory phasic spectral flow.
Persistent retrograde flow exceeding 1500 milliseconds during release of distal calf compression.
Vigorous pulsatile arterialized waveforms within the saphenous compartment with peak systolic velocities over 250 cm/s.
A completely non-compressible, thickened, echogenic vein lumen displaying complete absence of color and spectral Doppler flow.
Sections you finish are checked off in the contents.